Molex Expands European Manufacturing Footprint and Capabilities with State-of-the-Art Campus in Poland
- Written by Media Outreach
- New campus will facilitate timely product delivery of advanced medical devices and electrification solutions to customers in Europe
- Significant investment expands Molex's European footprint with up to 85,000 square meters of world-class manufacturing capacity
- Strategic location provides access to manufacturing and engineering talent to support the creation of hundreds of new skilled jobs
Molex's cutting-edge Katowice campus expands regional manufacturing capacity to facilitate timely product delivery of advanced medical devices and electrification solutions to European customers.
"The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market," said Paul Chaffin, Phillips-Medisize SVP and president of Molex Medical and Pharma Solutions. "This ultimately allows us to further our vision of enabling patients all over the world to live healthier, more productive lives. We look forward to becoming an active part of the local community, as we work together to create significant value for our customers, our new team members and ultimately patients."
The new Molex Katowice campus reflects a significant investment that will deliver state-of-the art capabilities in a world-class manufacturing facility and create hundreds of new skilled jobs in this strategic location.
Molex has so far invested $110 million in these world-class facilities that will initially support Phillips-Medisize with production of pharmaceutical, medical and diagnostic devices. The site will have state-of-the-art capabilities, including advanced medical device assembly, packaging, drug handling and injection molding. Additionally, the campus will manufacture interconnect battery solutions for electric vehicles and high-power busbar solutions for Molex's electrification business.Katowice will complement Phillips-Medisize's existing operations at six European manufacturing sites in Donegal and Sligo, Ireland; Struer, Denmark; Trhove Sviny, Czech Republic; and two locations in Kontiolahti, Finland.
The large pool of skilled manufacturing and engineering resources in the Katowice area was a major factor influencing Molex's selection of the site location. At planned capacity, the first facilities within the campus will employ approximately 350 employees, including highly skilled production operators, design engineers and quality specialists.
Combining high technology expertise and skilled labor means that both Phillips-Medisize medical customers and Molex automotive and electrification customers now have access to the company's expert capabilities, high-quality services and support in a location that enables speed-to-market and superior quality in product delivery.
The campus will be the first site for both Molex and Phillips-Medisize to hold a LEED Gold certification. ISO 13485 certification is pending construction completion, with additional certifications and registrations to follow, offering more localized value to those customers who require this exacting manufacturing quality.
Molex and Koch Industries in Poland
As Molex is part of Koch Industries, the Katowice campus will further increase the group's presence in Poland. Other Koch companies which have production facilities and service centers in Poland are Guardian Glass, SRG Global, Infor and Koch Business Solutions, which collectively employ nearly 2,400 people.
Hashtag: #Molex
The issuer is solely responsible for the content of this announcement.
